Olivia Willis
speaker
783 appearances
14 recordings
2 series
first heard Oct 2017
last heard May 2021
Olivia Willis’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsNo recordings in the last 12 months.Older appearances are listed below; set an alert to hear about the next one.
Appearances
very much.
Danielle Matzer is a Professor of General Practice at Monash University and Primary Chief Investigator at Monash's Centre of Research Excellence in Sexual and Reproductive Health for Women.
And in a statement to the Health Report, the Office of the Attorney-General said the Religious Freedom Bill does not prioritise religious views over patient health and that the provisions related to conscientious objection protect the existing abilities of doctors and medical professionals at a state and territory level.
To Queensland now, where researchers have identified a promising new drug combination that could significantly help the immune system target cancer cells and kill them.
Monoclonal antibodies are immunotherapy drugs designed to enlist the body's immune system to fight cancer.
One of the ways they work is by essentially sticking a flag in cancer cells so that the body's natural killer immune cells can spot them and come and attack the cancer.
But in certain cancers, like head and neck and some types of breast cancer, these drugs only work in about 15% of patients.
When they don't work, the drug target is difficult to reach and there's no response in the patient, so they just experience the side effects.
Associate Professor Fiona Simpson has been working for years on a way to predict who the drugs will work on and turn non-responders into responders.
In new work published in Cell, Dr Simpson has shown that by locking the drug targets into place on the surface of the tumour cells, you can improve the response of patients the drugs don't typically work on.
It all starts with a travel sickness drug many Australians already use.
And so with this process what you're doing is you're delivering the antibody treatment as normal but in conjunction you're delivering this anti-nausea drug which is effectively changing the surface of the tumor cell so that it is recognizable to the immune system and then the immune system can respond.
And where is the research up to?
You've looked at the treatment in mice, in tumors from head and neck cancer, breast cancer, colorectal cancers,
Depending on what happens, obviously, with the phase two trials, what's your hope if they're shown to be successful?
I mean, is this kind of paving the way, in a sense, for almost a new field of therapeutic intervention when it comes
Well, Fiona, best of luck with the Phase 2 trials and thank you so much for joining me.
Thank you.
Fiona Simpson is an Associate Professor at the University of Queensland's Diamantina Institute and Principal Fellow of the Queensland Head and Neck Cancer Centre.
And as the coronavirus outbreak continues, you can keep up to date with the ABC's new podcast.
Showing 281–300 of 783 · page 15 of 40
← Previous
Next →